Close Menu

Burrill & Co.

NEW YORK (GenomeWeb News) – Strand Life Sciences today said that financial services firm Burrill & Co. has invested in the firm's Series B round of financing.

This article has been updated to clarify that the bankruptcy filing only applies to the Gene Logic subsidiary.

Under the agreement, the two companies will co-invest into life science opportunities in China.

The building, estimated to cost $6 million, would include space configurable for either laboratory or light industrial use, designed for life-sci users that do not need the intensive use of utilities available in more traditional lab buildings.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.